Literature DB >> 9576125

Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites.

J He1, M J Klag, L J Appel, J Charleston, P K Whelton.   

Abstract

Many studies have suggested that African Americans have a higher prevalence of hypertension than whites. The authors conducted a prospective study of hypertension incidence from 1987-1988 to 1994-1995 in 140 African American and 237 white adults aged 30 to 54 years at baseline. The study participants were screened for participation in the Trials of Hypertension Prevention, phase 1, an 18-month lifestyle modification intervention trial aimed at lowering blood pressure, at the Baltimore Clinical Center. Baseline age, blood pressure, body mass index, and heart rate were similar in the two groups. Compared with whites, however, African Americans had a lower percentage of men, college graduates, and households with an income > or = $40,000 per year. African Americans also had lower mean urinary sodium to creatinine ratio and potassium to creatinine ratio, but a similar sodium to potassium ratio. The incidence of hypertension (blood pressure > or = 160/95 mm Hg and/or taking antihypertensive medication) over 7 years of follow-up was nearly identical: 25.7% in African Americans and 25.3% in whites. Baseline age, gender, blood pressure, and heart rate were all associated with the incidence of hypertension. Even after adjustment for these covariables, the risk of hypertension was not higher in African Americans compared with whites. These results indicate that middle-aged African Americans and whites have a similar risk of developing hypertension given the same age, initial blood pressure, and body mass index at baseline.

Entities:  

Mesh:

Year:  1998        PMID: 9576125     DOI: 10.1161/01.hyp.31.5.1130

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  9 in total

1.  Late life socioeconomic status and hypertension in an aging cohort: the Atherosclerosis Risk in Communities Study.

Authors:  M Maya McDoom; Priya Palta; Priya Vart; Stephen P Juraschek; Anna Kucharska-Newton; Ana V Diez Roux; Josef Coresh
Journal:  J Hypertens       Date:  2018-06       Impact factor: 4.844

Review 2.  Body mass index, abdominal fatness, and hypertension incidence: a dose-response meta-analysis of prospective studies.

Authors:  Wen Zhou; Yuanyuan Shi; Yu-Qian Li; Zhiguang Ping; Chongjian Wang; Xuejiao Liu; Jie Lu; Zhen-Xing Mao; Jingzhi Zhao; Lei Yin; Dongdong Zhang; Zhongyan Tian; Lulu Zhang; Linlin Li
Journal:  J Hum Hypertens       Date:  2018-03-27       Impact factor: 3.012

3.  Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study.

Authors:  Deborah A Levine; Cora E Lewis; O Dale Williams; Monika M Safford; Kiang Liu; David A Calhoun; Yongin Kim; David R Jacobs; Catarina I Kiefe
Journal:  Hypertension       Date:  2010-12-06       Impact factor: 10.190

4.  Ethnic differences in hypertension incidence among middle-aged and older adults: the multi-ethnic study of atherosclerosis.

Authors:  April P Carson; George Howard; Gregory L Burke; Steven Shea; Emily B Levitan; Paul Muntner
Journal:  Hypertension       Date:  2011-04-18       Impact factor: 10.190

Review 5.  Omega 3 fatty acids for prevention and treatment of cardiovascular disease.

Authors:  L Hooper; R L Thompson; R A Harrison; C D Summerbell; H Moore; H V Worthington; P N Durrington; A R Ness; N E Capps; G Davey Smith; R A Riemersma; S B J Ebrahim
Journal:  Cochrane Database Syst Rev       Date:  2004-10-18

6.  Racial Differences in the Incidence of Cardiovascular Risk Factors in Older Black and White Adults.

Authors:  George Howard; Monika M Safford; Claudia S Moy; Virginia J Howard; Dawn O Kleindorfer; Fredrick W Unverzagt; Elsayed Z Soliman; Matthew L Flaherty; Leslie A McClure; Daniel T Lackland; Virginia G Wadley; LeaVonne Pulley; Mary Cushman
Journal:  J Am Geriatr Soc       Date:  2016-09-26       Impact factor: 5.562

7.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-11-30

8.  Proinflammation and hypertension: a population-based study.

Authors:  Vanhala Mauno; Kautiainen Hannu; Kumpusalo Esko
Journal:  Mediators Inflamm       Date:  2008-12-30       Impact factor: 4.711

Review 9.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.

Authors:  Asmaa S Abdelhamid; Tracey J Brown; Julii S Brainard; Priti Biswas; Gabrielle C Thorpe; Helen J Moore; Katherine Ho Deane; Fai K AlAbdulghafoor; Carolyn D Summerbell; Helen V Worthington; Fujian Song; Lee Hooper
Journal:  Cochrane Database Syst Rev       Date:  2018-07-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.